cimb-logo

Journal Browser

Journal Browser

Announcements

26 April 2024
Meet Us at the 57th European Human Genetics Conference (ESHG 2024), 1–4 June 2024, Berlin, Germany


Conference: The 57th European Human Genetics Conference (ESHG 2024)
Organization: European Society of Clinical Microbiology and Infectious Diseases
Date: 1–4 June 2024
Place: Berlin, Germany
Booth: #840 

MDPI will be attending ESHG 2024 as an exhibitor. This meeting will be held in Berlin, Germany, from 1 to 4 June 2024.

The enormous achievements in the field of human genetics during the last years are changing not only our understanding of genetics of diseases but also our research approaches and daily work in the clinic. Due to these new developments and insights, the traditional borders between clinical genetics, cytogenetics and molecular genetics as well as between research into monogenic and complex disorders are getting blurry. The Scientific Programme Committee (SPC) of the ESHG decided to reflect these changes in its updated abstract submission categories and discuss those results during the conference.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link: https://2024.eshg.org/.

15 April 2024
Meet Us at the 12th World Biomaterials Congress (WBC 2024), 26–31 May 2024, Daegu, Korea


MDPI will attend the 12th World Biomaterials Congress (WBC 2024) as an exhibitor. We invite researchers from different backgrounds to visit and share their latest ideas with us.

The WBC is a large-scale academic conference supported by the IUSBSE, a global association in the field of biomaterials. The 12th World Biomaterials Congress will attract more than 4,000 participants from all over the world. Participating experts can gather and share the latest information and knowledge in the diverse areas within biomaterials research.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.wbc2024.com/.

10 April 2024
Meet Us at the 48th FEBS Congress, 29 June–3 July 2024, Milan, Italy


Conference:
The 48th FEBS Congress
Date: 29 June–3 July 2024
Location: Milan, Italy

MDPI will be attending the 48th FEBS Congress at Booth #30, and we welcome researchers from different backgrounds to visit us and share their latest ideas.

The Italian Society of Biochemistry and Molecular Biology (SIB), founded in 1951, will host the event. The 48th FEBS Congress—“Mining biochemistry for human health and well-being”—welcomes scientists from Europe and other parts of the world.

The 48th FEBS Congress will present a broad-spectrum and ground-breaking scientific program in a fruitful collaboration with FEBS journals and representatives from FEBS Constituent Societies. The SIB and biochemical community are focusing on human health and well-being through molecular and cellular science approaches; this is a key social issue amid ongoing global transitions. Besides presenting the latest and emerging developments in biochemical sciences, the Congress will include dedicated education-oriented sessions, symposia organized by young biochemists, and biochemistry-related economic discussions. Industry representatives will also give presentations on the latest advances in commercial instrumentation.

The following MDPI journals will be represented:

If you plan to attend this conference, please start an online conversation with us. Our delegates look forward to meeting you in person and answering your questions. For more information about the conference, please visit the following website: https://2024.febscongress.org/.

8 April 2024
Meet Us at the 2024 ASCO Annual Meeting, 31 May–4 June 2024, Chicago, IL, USA


The 2024 ASCO Annual Meeting will take you to discover state-of-the-art research, groundbreaking treatments, and visionary insights, igniting your passion for oncology. This year's program will feature over 200 sessions, complementing Dr. Lynn Schuchter’s Presidential theme “The Art and Science of Cancer Care: From Comfort to Cure”.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://conferences.asco.org/am/attend.

2 April 2024
Join Us for the 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), 10–13 June 2024, Rotterdam, the Netherlands


The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four-day congress engaged in basic, preclinical and translational cancer research across a myriad of topics that is aiming to spotlight, inspire and unite the cancer research community to innovate, build knowledge, and create collaborations.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to contact us online. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following link: https://2024.eacr.org/.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

29 March 2024
Meet Us at the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024), 16–20 June 2024, Osaka, Japan


MDPI will be attending the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024) held in Osaka, Japan, from 16 to 20 June 2024. The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. This is the third time that the conference will be held in Japan, following the 2005 and 2014 conferences held in Tsuruoka. We look forward to welcoming the metabolomics community, building strong connections, and discussing world-class research in a relaxed collegial environment. Let us build on the momentum of the incredible Niagara Falls and Valencia conferences that brought us back together in person, and make it the best meeting of 2024 together!

During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest views and research with us.

The following MDPI journals will be represented:

  • Metabolites;
  • Biomolecules;
  • Plants;
  • IJMS;
  • Life;
  • Cells;
  • Agronomy;
  • Nutrients;
  • Cancers;
  • CIMB;
  • Genes;
  • Antioxidants.

If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: https://www.metabolomics2024.org/.

12 March 2024
Recruiting Editorial Board Members for the Current Issues in Molecular Biology


Current Issues in Molecular Biology (CIMB, ISSN: 1467-3045) is a peer-reviewed journal publishing original articles and reviews in all areas of molecular biology. To expand our contribution to molecular biology, Current Issues in Molecular Biology is recruiting researchers to join our Editorial Boards of the following Sections:

The main responsibilities of Editorial Board Members are as follows:

  • Making decisions on whether a manuscript should be accepted based on the reports we collect;
  • Suggesting special topics or editing a Special Issue on a topic related to your research;
  • Promoting CIMB and increasing its visibility at relevant academic conferences;
  • Advising on our journal’s development;
  • Helping to check Special Issue proposals.

If you are interested in this position, know of potential candidates you would recommend, or wish to request further information, please contact the CIMB Editorial Office. We look forward to hearing from you. 

CIMB Editorial Office

12 March 2024
Recruiting Topical Advisory Panel Members for Current Issues in Molecular Biology


The Editorial Office of the Current Issues in Molecular Biology (CIMB, ISSN: 1467-3045) is pleased to announce that applications are open for the Topical Advisory Panel. Should you decide to serve on the Topical Advisory Panel, you would be responsible for some of the following tasks, depending on your availability:

  • Providing regular reviews of manuscripts;
  • Setting up at least one Special Issue in partnership with a senior researcher within two years of taking on the role and proposing a detailed strategy plan for the Special Issue. The topic of the proposal should be within the scope of CIMB. The scope of the Special Issue should be broad enough to attract a reasonable number of submissions but narrow enough to provide a cohesive collection of articles. The Special Issue should cover a small part of the scope of CIMB;
  • Providing a detailed strategy plan for the Special Issue, including assisting in preparing the Special Issue’s title, aim and scope, summary, and keywords, soliciting papers, and promoting the Special Issue;
  • Supporting Special Issues related to your expertise when the Guest Editor is unavailable. This includes Special Issue promotion via social media and advising on some scientific cases;
  • Promoting our journal at conferences (adding one to two slides into presentations, distributing flyers, recommending the journal to your colleagues, etc.), on social media, and other relevant platforms;
  • Working with Editorial Board Members or the Editorial Office to promote high-quality/featured papers (for example, writing summaries or highlights for editor-selected papers).

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have expertise and experience in the field related to CIMB;
  • Have completed their Ph.D.;
  • Have published at least six papers in the last 5 years as a first or corresponding author.

Each year, the members’ performance is evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief. Please click on the following link to submit your application: https://www.mdpi.com/journal/cimb/topical_advisory_panel_application.

Please do not hesitate to contact the CIMB Editorial Office for further details and clarification.

CIMB Editorial Office

12 March 2024
Current Issues in Molecular Biology | Call for Special Issue Proposals


Current Issues in Molecular Biology (CIMB, ISSN: 1467-3045) is an international, peer-reviewed, and open access journal on all aspects of molecular biology.

The CIMB editorial team is pleased to announce an open call for Special Issue proposals. This Special Issue will offer a group of authors the opportunity to work on an interconnected set of papers on an innovative topic. We welcome high-quality proposals that will be evaluated in an ongoing selection process throughout the year.

In order to ensure that the topic of your proposal is within the scope of CIMB, please read the aim and scope of Current Issues in Molecular Biology at the following website: https://www.mdpi.com/journal/cimb/about.

Proposals for Special Issues should be sent to the Editorial Office or submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/cimb.

The following information should be provided in a proposal:

  • A 150–200-word summary that clearly states the significance, novelty, technical advancement, and adherence to the scope of the journal of the proposed topic;
  • A list of 5–10 keywords related to the topic;
  • A brief resume of the proposed Guest Editors, together with their information (title, name, email, affiliation, personal website, and keywords of their research interests);
  • A proposed submission deadline (a Special Issue will usually be open for submissions for 6–8 months);
  • A list of at least 20 potential contributors or a list of 8 planned papers.

As a Guest Editor, you would be responsible for:

  • Inviting your peers to submit papers to be published in your Special Issue. These papers will be able to take advantage of the high publicity offered by our open access publishing, our rapid and high-quality peer review process, and immediate publication after acceptance;
  • Checking the suitability of abstracts/manuscripts submitted to the Special Issue;
  • Making pre-check decisions regarding whether to send a new submission to peer review;
  • Making final decisions regarding whether to accept a paper based on peer review outcomes.

As a Guest Editor, you would have the following privileges:

  • A certificate of recognition as a Guest Editor of CIMB;
  • The ability to publish one Feature Paper in your Special Issue;
  • The ability to invite authors to submit high-quality papers to be published in your Special Issue with discounts;
  • If the Special Issue is successful and features at least 10 manuscripts accepted after full peer review, we can organize it into a printed book and send you a free copy as a gift.

The Editorial Office will set up the Special Issue website, arrange the promotional material, assist with invitations for paper contributions, take care of the administrative tasks associated with peer review, including inviting reviewers, collating reports, contacting authors, and arranging professional production before publication.

Please do not hesitate to contact our Editorial Office if you are interested and would like further details or clarification.

We look forward to receiving your proposals.

CIMB Editorial Office


Back to TopTop